Association of Antipsychotic Treatment With Risk of Unexpected Death Among Children and Youths

Authors:

Abstract
The introduction of second-generation antipsychotics led to a marked increase in antipsychotic medication prescribing for children and youths.1-3 In 2010, more than 1.3 million individuals receiving antipsychotics aged 24 years or younger filled 7 million antipsychotic medication prescriptions.4,5 The most common diagnoses associated with the antipsychotic prescriptions for these children and young adults were attention-deficit/hyperactivity disorder (ADHD), disruptive behavior disorder, and depression.4,5 However, antipsychotics are often an off-label or secondary therapeutic choice for these diagnoses, given the other well-defined therapeutic interventions available with potentially fewer adverse effects.5 Antipsychotics also are frequently prescribed to children and adolescents for bipolar disorder or mood instability, although there often are alternative treatments available.5

This publication has 74 references indexed in Scilit: